Literature DB >> 823712

Mucocutaneous lymph node syndrome with encephalopathy in the continental United States.

I B Bernhardt.   

Abstract

Entities:  

Mesh:

Year:  1976        PMID: 823712      PMCID: PMC1237287     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  7 in total

1.  POLYARTERITIS NODOSA IN INFANCY.

Authors:  F B ROBERTS; G H FETTERMAN
Journal:  J Pediatr       Date:  1963-10       Impact factor: 4.406

2.  Infantile periarteritis nodosa with coronary and brachial aneurysms: a case diagnosed during life.

Authors:  J L Chamberlain; L W Perry
Journal:  J Pediatr       Date:  1971-06       Impact factor: 4.406

3.  Myocardial infarction due to coronary thromboarteritis, following acute febrile mucocutaneous lymph node syndrome (MLNS) in an infant.

Authors:  M Yanagisawa; N Kobayashi; S Matsuya
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

4.  Mucocutaneous lymph node syndrome (MLNS): a disease widespread in Japan which demands our attention.

Authors:  G H Fetterman; Y Hashida
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

5.  Multiple coronary-artery aneurysms in a child with angina pectoris.

Authors:  D E McMartin; A J Stone; R H Franch
Journal:  N Engl J Med       Date:  1974-03-21       Impact factor: 91.245

6.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

Authors:  T Kawasaki; F Kosaki; S Okawa; I Shigematsu; H Yanagawa
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

7.  Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome.

Authors:  H Kato; S Koike; M Yamamoto; Y Ito; E Yano
Journal:  J Pediatr       Date:  1975-06       Impact factor: 4.406

  7 in total
  1 in total

1.  Mucocutaneous lymph node syndrome with necrotic pharyngitis.

Authors:  L Brion; M Courtoy; D Bachelart; H Szliwowski; M Dickstein; M Heenen; M Tondeur
Journal:  Eur J Pediatr       Date:  1980-10       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.